The number of people with susceptibility test result for rifampicin in Russian Federation
Russian Federation: The number of people with susceptibility test result for rifampicin was 21,391 in 2021. ▼ Falling
Latest (2021)
21,391
Change on year
up 1.4%
World rank
15th
of 155 countries
All-time high
29,081
in 2017
All-time low
21,099
in 2020
Years of data
5
2017–2021
The number of people with susceptibility test result for rifampicin in Russian Federation, 2017–2021
Source: World Health Organization, Global Health Observatory.
Analysis
The most recent figure for the number of people with susceptibility test result for rifampicin in Russian Federation is 21,391, measured in 2021.
Compared with earlier readings it is up 1.4% on the previous year and down 26.4% over five years.
Russian Federation ranks 15th of 155 countries on this measure, in the top 10%.
The number of people with susceptibility test result for rifampicin in Russian Federation, year by year
| Year | Value | Change |
|---|---|---|
| 2017 | 29,081 | — |
| 2018 | 27,960 | -3.9% |
| 2019 | 26,189 | -6.3% |
| 2020 | 21,099 | -19.4% |
| 2021 | 21,391 | +1.4% |
Russian Federation compared with similar countries
- Russian Federation's 21,391 is above the median for high income countries, which is 142, 150.6× the median. (61 countries reporting)
- Russian Federation's 21,391 is above the median for Europe & Central Asia, which is 229.5, 93.2× the median. (44 countries reporting)
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2010s | 27,743 | 26,189 | 29,081 | 3 |
| 2020s | 21,245 | 21,099 | 21,391 | 2 |
Countries ranked near Russian Federation
More health data for Russian Federation
- Un projection of annual infant deaths, annual growth rate -0.7261 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate -0.5159 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 1,176 deaths per 1,000 people (2090)
- Number of infants who die before age 1 957 deaths (2100)
- Neonatal tetanus - number of reported cases, gaps filled 0 (2025)
- Population ages 00-04, female, annual growth rate -3.34 % change on previous year (2025)
- Population ages 00-04, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 00-04, female, per capita 0.0224 units per person (2025)
- Population ages 00-04, male, annual growth rate -3.3 % change on previous year (2025)
- Population ages 00-04, male, per unit of GDP 0 units per US$ of GDP (2025)
Frequently asked questions
- What is the number of people with susceptibility test result for rifampicin in Russian Federation?
- The number of people with susceptibility test result for rifampicin in Russian Federation was 21,391 in 2021, according to World Health Organization, Global Health Observatory.
- What is the highest the number of people with susceptibility test result for rifampicin recorded in Russian Federation?
- The highest recorded value was 29,081 in 2017.
- What is the lowest the number of people with susceptibility test result for rifampicin recorded in Russian Federation?
- The lowest recorded value was 21,099 in 2020.
- How does Russian Federation rank for the number of people with susceptibility test result for rifampicin?
- Russian Federation ranks 15th out of 155 countries with data for 2021.
- Where does this Russian Federation data come from?
- The figures come from World Health Organization, Global Health Observatory, published as part of The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.. Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 5 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).